Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Albemarle Reports Third Quarter Growth

      Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation)

      News provided by

      Albemarle Corporation

      Nov 06, 2019, 16:15 ET

      Share this article

      Share this article


      CHARLOTTE, N.C., Nov. 6, 2019 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB) today announced its results for the third quarter ended Sept. 30, 2019.

      Third Quarter 2019 Highlights
      (Based on year-over-year comparisons unless otherwise noted)

      • Net sales of $879.7 million increased 14%, excluding foreign exchange impact of 1%, largely driven by strong volume and favorable pricing
      • Earnings were $1.46 per diluted share, an increase of 22%
      • Adjusted EPS were $1.53 per diluted share, an increase of 17%
      • Adjusted EBITDA was $254.4 million, an increase of 8%

      Notable Developments

      • Completed previously announced lithium joint venture with Mineral Resources Limited on Oct. 31, 2019; funded Wodgina mine project and other general corporate projects with $1 billion, borrowed from new $1.2 billion unsecured credit facility
      • Previously announced Company's full year 2019 adjusted diluted EPS outlook is $6.00 - $6.20 from $6.25 - $6.65
      • Initiating cost management program targeting over $100 million in savings over a two-year period

      "During the third quarter, Albemarle grew net sales by 14%, adjusted EBITDA by 12%, and adjusted earnings per share by 22% over the prior year, excluding currency impacts, due to solid growth across all businesses," said Luke Kissam, Albemarle CEO. "We have recently made several strategic decisions to further position Albemarle for long-term success and remain confident in the long-term growth prospects of our business."

      Third Quarter Results

      In millions, except per share amounts

      Q3 2019


      Q3 2018


      $ Change


      % Change

      Net sales

      $

      879.7



      $

      777.7



      $

      102.0



      13.1

      %

      Net income attributable to Albemarle Corporation

      $

      155.1



      $

      129.7



      $

      25.3



      19.5

      %

      Adjusted EBITDA(a)

      $

      254.4



      $

      235.1



      $

      19.3



      8.2

      %

      Diluted earnings per share

      $

      1.46



      $

      1.20



      $

      0.26



      21.7

      %

         Non-operating pension and OPEB items(a)

      (0.01)



      (0.02)






         Non-recurring and other unusual items(a)

      0.08



      0.13






      Adjusted diluted earnings per share(b)

      $

      1.53



      $

      1.31



      $

      0.22



      16.8

      %

      (a)     See Non-GAAP Reconciliations for further details.
      (b)     Totals may not add due to rounding.

      • Net sales increased 14%, in constant currencies, due to increased volume in all reportable segments and favorable pricing in Lithium and Bromine Specialties.
      • The Company's earnings increased as a result of earnings growth from each of the businesses, lower interest and financing expenses, and a lower effective tax rate. The increase was partially offset by unfavorable currency exchange, higher corporate costs for professional services, and increased depreciation and amortization due to increased capital projects put into service.

      Third Quarter Business Segment Results

      Lithium

      In millions

      Q3 2019


      Q3 2018


      $ Change


      % Change

      Net Sales

      $

      330.4



      $

      270.9



      $

      59.5



      21.9

      %

      Adjusted EBITDA

      $

      127.5



      $

      113.6



      $

      13.8



      12.2

      %

      • Net sales and adjusted EBITDA growth were driven by increased volume and slightly favorable pricing of 1%, which more than offset deferred shipments due to disruption caused by Typhoon Tapah in late September. As previously communicated, impacted volume is expected to be fully recovered in the fourth quarter.
      • Net sales reflects unfavorable currency exchange of 1%. Adjusted EBITDA reflects favorable currency exchange of 4% resulting from a weaker Chilean Peso.
      • Cost of goods sold increased, mainly due to higher tolling product costs to meet customer commitments and address operating issues in La Negra, Chile.
      • Out-of-period non-cash expense of $7.0 million recorded in the third quarter of 2019 in cost of goods sold was due to an adjustment of lithium carbonate inventory values from the second quarter of 2019.
      • Please see press release issued Oct. 24, 2019 for additional information.

      Bromine Specialties

      In millions

      Q3 2019


      Q3 2018


      $ Change


      % Change

      Net Sales

      $

      256.3



      $

      232.6



      $

      23.7



      10.2

      %

      Adjusted EBITDA

      $

      88.8



      $

      78.6



      $

      10.2



      13.0

      %

      • Net sales and adjusted EBITDA growth reflects favorable price impacts and increased volume, more than offsetting unfavorable currency exchange of 1%.

      Catalysts

      In millions

      Q3 2019


      Q3 2018


      $ Change


      % Change

      Net Sales

      $

      261.3



      $

      251.1



      $

      10.2



      4.1

      %

      Adjusted EBITDA

      $

      66.9



      $

      62.6



      $

      4.3



      6.9

      %

      • Favorable pricing in Fluid Catalytic Cracking (FCC) Catalysts was offset by lower volumes related to delays in the start-up of new FCC units.
      • Clean Fuel Technology, or HPC, benefited from higher sales volume and a favorable product mix.
      • Net sales reflects unfavorable currency exchange of 1%.
      • Results also reflect a partial insurance claim reimbursement of $2.2 million received in 2018.

      All Other

      In millions

      Q3 2019


      Q3 2018


      $ Change


      % Change

      Net Sales

      $

      31.7



      $

      23.1



      $

      8.7



      37.6

      %

      Adjusted EBITDA

      $

      10.4



      $

      4.0



      $

      6.5



      163.3

      %

      • Net sales growth reflects increased sales volume of $9.3 million in our fine chemistry services business.
      • Results also reflect a $4.4 million decrease from the re-measurement of the fair value of our investment in private equity securities.

      Corporate Results

      In millions

      Q3 2019


      Q3 2018


      $ Change


      % Change

      Adjusted EBITDA

      $

      (39.3)



      $

      (23.7)



      $

      (15.6)



      65.9

      %
















      • Results reflect higher selling, general and administrative spending for professional services and $11.3 million of unfavorable currency exchange impacts.

      Income Taxes

      The effective income tax rate for the third quarter of 2019 was 15.5% compared to 21.5% in the same period in 2018, largely due to change in geographic earnings mix. On an adjusted basis, the effective income tax rates were 15.0% and 18.9% for the third quarter of 2019 and 2018, respectively.

      Cash Flow and Capital Deployment

      Cash from operations was $345.6 million for the nine months ended Sept. 30, 2019, a decrease of $31.3 million versus the same period in 2018. The result was primarily due to the timing on payables and the collection of certain receivables, lower cash earnings in Catalysts, and higher cash taxes. This was partially offset by higher dividends received from unconsolidated investments and increased cash earnings from Bromine Specialties.

      Capital expenditures were $608.5 million as compared to $471.7 million in the first nine months of 2018, with the increase driven largely by expansion in our Lithium business. As previously announced in the second quarter, Albemarle reduced its multi-year capital expenditure plan to approximately $3.5 billion from $5.0 billion over the next five years. This adjustment reflects the Company's commitment to generating free cash in 2021 and investing capital where customer volume and price commitments provide an attractive return.

      During the nine months ended Sept. 30, 2019, Albemarle deployed dividends to shareholders totaling $113.3 million.

      Cash and cash equivalents were $317.8 million at Sept. 30, 2019, as compared to $555.3 million at Dec. 31, 2018.

      Full Year 2019 Outlook

      As previously announced on Oct. 24, 2019, discrete and operational items impacting Lithium will likely cause the business's fourth quarter 2019 performance to be lower than previously forecasted. The Company expects continued upside in Bromine Specialties and Catalysts in the fourth quarter, but does not expect this to offset the impact from Lithium on total Company results.

      As a result, Albemarle is reaffirming its full year 2019 guidance as follows:


      Current  Outlook


      vs Pro Forma

      Full Year 2018(a)

      Net sales

      $3.6 - $3.7 billion


      7% - 10%

      Adjusted EBITDA

      $1.02 - $1.06 billion


      2% - 6%

      Adjusted EPS (per diluted share)

      $6.00 - $6.20


      10% - 14%

      (a) Pro forma excludes the impact of the polyolefin catalysts and components business sold on April 1, 2018.

      Additionally, the Company expects its full year 2019 income tax rate to be between 18% and 19%.

      Earnings Call

      Date:

      Thursday, Nov. 7, 2019

      Time:

      9:00 AM Eastern time

      Dial-in (U.S.):

      844-347-1034

      Dial-in (International):

      209-905-5910

      Passcode:

      6199517

      The Company's earnings presentation and supporting material is available on Albemarle's website at https://investors.albemarle.com.

      About Albemarle

      Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, N.C., is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics. Working side-by-side with our customers, we develop value-added, customized solutions that make them more competitive. Our solutions combine the finest technology and ingredients with the knowledge and know-how of our highly experienced and talented team of operators, scientists and engineers.

      Discovering and implementing new and better performance-based sustainable solutions is what motivates all of us. We think beyond business-as-usual to drive innovations that create lasting value. Albemarle employs approximately 5,600 people and serves customers in approximately 100 countries. We regularly post information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information regarding our company, its businesses and the markets it serves.

      Forward-Looking Statements

      Some of the information presented in this press release, the conference call and discussions that follow, including, without limitation, information related to product development, production capacity, committed volumes, market trends, pricing, expected growth, earnings and demand for our products, input costs, surcharges, tax rates, stock repurchases, dividends, cash flow generation, costs and cost synergies, capital projects, economic trends, outlook and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the views expressed. Factors that could cause actual results to differ materially from the outlook expressed or implied in any forward-looking statement include, without limitation: changes in economic and business conditions; changes in financial and operating performance of our major customers and industries and markets served by us; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in the demand for our products or the end-user markets in which our products are sold; limitations or prohibitions on the manufacture and sale of our products; availability of raw materials; increases in the cost of raw materials and energy, and our ability to pass through such increases to our customers; changes in our markets in general; fluctuations in foreign currencies; changes in laws and government regulation impacting our operations or our products; the occurrence of regulatory actions, proceedings, claims or litigation; the occurrence of cyber-security breaches, terrorist attacks, industrial accidents, natural disasters or climate change; the inability to maintain current levels of product or premises liability insurance or the denial of such coverage; political unrest affecting the global economy, including adverse effects form terrorism or hostilities; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of our earnings and changes in tax laws and rates; changes in monetary policies, inflation or interest rates that may impact our ability to raise capital or increase our cost of funds, impact the performance of our pension fund investments and increase our pension expense and funding obligations; volatility and uncertainties in the debt and equity markets; technology or intellectual property infringement, including cyber-security breaches, and other innovation risks; decisions we may make in the future; the ability to successfully execute, operate and integrate acquisitions and divestitures; and the other factors detailed from time to time in the reports we file with the SEC, including those described under "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. These forward-looking statements speak only as of the date of this press release. We assume no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

      Albemarle Corporation and Subsidiaries
      Consolidated Statements of Income
      (In Thousands Except Per Share Amounts) (Unaudited)


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2019


      2018


      2019


      2018

      Net sales

      $

      879,747



      $

      777,748



      $

      2,596,863



      $

      2,453,251


      Cost of goods sold

      569,880



      497,211



      1,677,596



      1,556,379


      Gross profit

      309,867



      280,537



      919,267



      896,872


      Selling, general and administrative expenses

      108,135



      100,167



      348,205



      325,174


      Research and development expenses

      15,585



      16,610



      44,024



      53,670


      Gain on sale of business

      —



      —



      —



      (218,705)


      Operating profit

      186,147



      163,760



      527,038



      736,733


      Interest and financing expenses

      (11,108)



      (12,988)



      (35,295)



      (39,834)


      Other (expenses) income, net

      (11,316)



      3,793



      (7,090)



      (31,906)


      Income before income taxes and equity in net income of
      unconsolidated investments

      163,723



      154,565



      484,653



      664,993


      Income tax expense

      25,341



      33,167



      93,266



      133,630


      Income before equity in net income of unconsolidated
      investments

      138,382



      121,398



      391,387



      531,363


      Equity in net income of unconsolidated investments (net of
      tax)

      33,236



      22,081



      106,727



      61,727


      Net income

      171,618



      143,479



      498,114



      593,090


      Net income attributable to noncontrolling interests

      (16,548)



      (13,734)



      (55,277)



      (29,124)


      Net income attributable to Albemarle Corporation

      $

      155,070



      $

      129,745



      $

      442,837



      $

      563,966


      Basic earnings per share

      $

      1.46



      $

      1.21



      $

      4.18



      $

      5.16


      Diluted earnings per share

      $

      1.46



      $

      1.20



      $

      4.16



      $

      5.11










      Weighted-average common shares outstanding – basic

      105,999



      107,315



      105,920



      109,223


      Weighted-average common shares outstanding – diluted

      106,299



      108,302



      106,324



      110,276


      Albemarle Corporation and Subsidiaries
      Condensed Consolidated Balance Sheets
      (In Thousands) (Unaudited)


      September 30,


      December 31,


      2019


      2018

      ASSETS




      Current assets:




      Cash and cash equivalents

      $

      317,823



      $

      555,320


      Trade accounts receivable

      637,037



      605,712


      Other accounts receivable

      86,556



      52,059


      Inventories

      802,434



      700,540


      Other current assets

      125,902



      84,790


      Total current assets

      1,969,752



      1,998,421


      Property, plant and equipment

      5,406,123



      4,799,063


      Less accumulated depreciation and amortization

      1,882,086



      1,777,979


      Net property, plant and equipment

      3,524,037



      3,021,084


      Investments

      551,657



      528,722


      Other assets

      200,858



      80,135


      Goodwill

      1,534,241



      1,567,169


      Other intangibles, net of amortization

      361,058



      386,143


      Total assets

      $

      8,141,603



      $

      7,581,674


      LIABILITIES AND EQUITY




      Current liabilities:




      Accounts payable

      $

      527,052



      $

      522,516


      Accrued expenses

      273,709



      257,323


      Current portion of long-term debt

      539,960



      307,294


      Dividends payable

      38,678



      35,169


      Current operating lease liability

      24,606



      —


      Income taxes payable

      17,238



      60,871


      Total current liabilities

      1,421,243



      1,183,173


      Long-term debt

      1,381,984



      1,397,916


      Postretirement benefits

      45,752



      46,157


      Pension benefits

      272,345



      285,396


      Other noncurrent liabilities

      618,822



      526,942


      Deferred income taxes

      393,120



      382,982


      Commitments and contingencies




      Equity:




      Albemarle Corporation shareholders' equity:




      Common stock

      1,060



      1,056


      Additional paid-in capital

      1,379,419



      1,368,897


      Accumulated other comprehensive loss

      (435,977)



      (350,682)


      Retained earnings

      2,892,057



      2,566,050


      Total Albemarle Corporation shareholders' equity

      3,836,559



      3,585,321


      Noncontrolling interests

      171,778



      173,787


      Total equity

      4,008,337



      3,759,108


      Total liabilities and equity

      $

      8,141,603



      $

      7,581,674


      Albemarle Corporation and Subsidiaries
      Selected Consolidated Cash Flow Data
      (In Thousands) (Unaudited)


      Nine Months Ended

       September 30,


      2019


      2018

      Cash and cash equivalents at beginning of year

      $

      555,320



      $

      1,137,303


      Cash flows from operating activities:




      Net income

      498,114



      593,090


      Adjustments to reconcile net income to cash flows from operating activities:




      Depreciation and amortization

      156,718



      150,511


      Gain on sale of business

      —



      (218,705)


      Gain on sale of property

      (11,079)



      —


      Stock-based compensation and other

      15,169



      11,785


      Equity in net income of unconsolidated investments (net of tax)

      (106,727)



      (61,727)


      Dividends received from unconsolidated investments and nonmarketable
      securities

      62,982



      32,794


      Pension and postretirement expense (benefit)

      1,641



      (2,708)


      Pension and postretirement contributions

      (10,728)



      (11,068)


      Unrealized gain on investments in marketable securities

      (1,701)



      (1,615)


      Deferred income taxes

      7,726



      43,400


      Working capital changes

      (289,587)



      (131,813)


      Other, net

      23,110



      (27,003)


      Net cash provided by operating activities

      345,638



      376,941


      Cash flows from investing activities:




      Acquisitions, net of cash acquired

      —



      (11,403)


      Capital expenditures

      (608,456)



      (471,675)


      Cash proceeds from divestitures, net

      —



      413,479


      Proceeds from sale of property and equipment

      10,356



      —


      Sales of (investments in) marketable securities, net

      1,177



      (761)


      Investments in equity and other corporate investments

      (2,569)



      (5,346)


      Net cash used in investing activities

      (599,492)



      (75,706)


      Cash flows from financing activities:




      Other borrowings (repayments), net

      232,183



      (134,505)


      Dividends paid to shareholders

      (113,321)



      (108,922)


      Dividends paid to noncontrolling interests

      (57,212)



      (14,756)


      Repurchases of common stock

      —



      (500,000)


      Proceeds from exercise of stock options

      4,814



      2,302


      Withholding taxes paid on stock-based compensation award distributions

      (10,774)



      (17,047)


      Other

      (445)



      —


      Net cash provided by (used in) financing activities

      55,245



      (772,928)


      Net effect of foreign exchange on cash and cash equivalents

      (38,888)



      (24,384)


      Decrease in cash and cash equivalents

      (237,497)



      (496,077)


      Cash and cash equivalents at end of period

      $

      317,823



      $

      641,226


      Albemarle Corporation and Subsidiaries
      Consolidated Summary of Segment Results
      (In Thousands) (Unaudited)


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2019


      2018


      2019


      2018

      Net sales:








      Lithium

      $

      330,386



      $

      270,928



      $

      947,030



      $

      886,523


      Bromine Specialties

      256,267



      232,616



      760,752



      678,769


      Catalysts

      261,346



      251,139



      779,295



      796,822


      All Other

      31,748



      23,065



      109,786



      90,978


      Corporate

      —



      —



      —



      159


      Total net sales

      $

      879,747



      $

      777,748



      $

      2,596,863



      $

      2,453,251










      Adjusted EBITDA:








      Lithium

      $

      127,459



      $

      113,629



      $

      384,854



      $

      386,260


      Bromine Specialties

      88,814



      78,585



      248,743



      217,921


      Catalysts

      66,944



      62,602



      193,890



      205,534


      All Other

      10,448



      3,968



      28,931



      7,729


      Corporate

      (39,314)



      (23,702)



      (114,300)



      (75,082)


      Total adjusted EBITDA

      $

      254,351



      $

      235,082



      $

      742,118



      $

      742,362


      See accompanying non-GAAP reconciliations below.

      Additional Information

      It should be noted that adjusted net income attributable to Albemarle Corporation, adjusted diluted earnings per share, non-operating pension and OPEB items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA, EBITDA margin and adjusted EBITDA margin are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to Net income attributable to Albemarle Corporation ("earnings"). These measures are presented here to provide additional useful measurements to review our operations, provide transparency to investors and enable period-to-period comparability of financial performance. The Company's chief operating decision maker uses these measures to assess the ongoing performance of the Company and its segments, as well as for business and enterprise planning purposes.

      A description of other non-GAAP financial measures that we use to evaluate our operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found on the following pages of this press release, which is also is available on Albemarle's website at https://investors.albemarle.com. The Company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the Company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the Company's results calculated in accordance with GAAP.

      ALBEMARLE CORPORATION AND SUBSIDIARIES
      Non-GAAP Reconciliations
      (Unaudited)

      See below for a reconciliation of adjusted net income attributable to Albemarle Corporation, EBITDA and adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation ("earnings"), the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted earnings is defined as earnings before the non-recurring, other unusual and non-operating pension and OPEB items as listed below. EBITDA is defined as earnings before interest and financing expenses, income taxes, and depreciation and amortization. Adjusted EBITDA is defined as EBITDA and the non-recurring, other unusual and non-operating pension and OPEB items as listed below.


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,

      In thousands, except percentages and per share amounts

      2019


      2018


      2019


      2018

      Net income attributable to Albemarle Corporation

      $

      155,070



      $

      129,745



      $

      442,837



      $

      563,966


      Add back:








      Non-operating pension and OPEB items (net of tax)

      (543)



      (1,856)



      (1,805)



      (5,595)


      Non-recurring and other unusual items (net of tax)

      8,497



      13,568



      17,239



      (121,731)


      Adjusted net income attributable to Albemarle Corporation

      $

      163,024



      $

      141,457



      $

      458,271



      $

      436,640










      Adjusted diluted earnings per share

      $

      1.53



      $

      1.31



      $

      4.31



      $

      3.96










      Weighted-average common shares outstanding – diluted

      106,299



      108,302



      106,324



      110,276










      Net income attributable to Albemarle Corporation

      $

      155,070



      $

      129,745



      $

      442,837



      $

      563,966


      Add back:








      Interest and financing expenses

      11,108



      12,988



      35,295



      39,834


      Income tax expense

      25,341



      33,167



      93,266



      133,630


      Depreciation and amortization

      54,487



      49,707



      156,718



      150,511


      EBITDA

      246,006



      225,607



      728,116



      887,941


      Non-operating pension and OPEB items

      (551)



      (2,195)



      (1,810)



      (6,596)


      Non-recurring and other unusual items

      8,896



      11,670



      15,812



      (138,983)


      Adjusted EBITDA

      $

      254,351



      $

      235,082



      $

      742,118



      $

      742,362










      Net sales

      $

      879,747



      $

      777,748



      $

      2,596,863



      $

      2,453,251


      EBITDA margin

      28.0

      %


      29.0

      %


      28.0

      %


      36.2

      %

      Adjusted EBITDA margin

      28.9

      %


      30.2

      %


      28.6

      %


      30.3

      %

      See below for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP (in thousands, except percentages).


      Lithium


      Bromine
      Specialties


      Catalysts


      Reportable
      Segments
      Total


      All Other


      Corporate


      Consolidated
      Total


      % of
      Net
      Sales

      Three months ended September 30, 2019:
















      Net income (loss) attributable to Albemarle
      Corporation

      $

      102,136



      $

      75,224



      $

      54,345



      $

      231,705



      $

      8,305



      $

      (84,940)



      $

      155,070



      17.6

      %

      Depreciation and amortization

      25,212



      12,448



      12,599



      50,259



      2,143



      2,085



      54,487



      6.2

      %

      Non-recurring and other unusual items

      111



      1,142



      —



      1,253



      —



      7,643



      8,896



      1.0

      %

      Interest and financing expenses

      —



      —



      —



      —



      —



      11,108



      11,108



      1.3

      %

      Income tax expense

      —



      —



      —



      —



      —



      25,341



      25,341



      2.9

      %

      Non-operating pension and OPEB items

      —



      —



      —



      —



      —



      (551)



      (551)



      (0.1)

      %

      Adjusted EBITDA

      $

      127,459



      $

      88,814



      $

      66,944



      $

      283,217



      $

      10,448



      $

      (39,314)



      $

      254,351



      28.9

      %

















      Three months ended September 30, 2018:
















      Net income (loss) attributable to Albemarle
      Corporation

      $

      90,313



      $

      67,967



      $

      50,491



      $

      208,771



      $

      1,978



      $

      (81,004)



      $

      129,745



      16.7

      %

      Depreciation and amortization

      23,370



      10,618



      12,111



      46,099



      1,990



      1,618



      49,707



      6.4

      %

      Non-recurring and other unusual items

      (54)



      —



      —



      (54)



      —



      11,724



      11,670



      1.5

      %

      Interest and financing expenses

      —



      —



      —



      —



      —



      12,988



      12,988



      1.7

      %

      Income tax expense

      —



      —



      —



      —



      —



      33,167



      33,167



      4.2

      %

      Non-operating pension and OPEB items

      —



      —



      —



      —



      —



      (2,195)



      (2,195)



      (0.3)

      %

      Adjusted EBITDA

      $

      113,629



      $

      78,585



      $

      62,602



      $

      254,816



      $

      3,968



      $

      (23,702)



      $

      235,082



      30.2

      %

















      Nine months ended September 30, 2019:
















      Net income (loss) attributable to Albemarle
      Corporation

      $

      312,609



      $

      212,320



      $

      156,328



      $

      681,257



      $

      22,629



      $

      (261,049)



      $

      442,837



      17.1

      %

      Depreciation and amortization

      71,669



      35,281



      37,562



      144,512



      6,302



      5,904



      156,718



      6.0

      %

      Non-recurring and other unusual items

      576



      1,142



      —



      1,718



      —



      14,094



      15,812



      0.6

      %

      Interest and financing expenses

      —



      —



      —



      —



      —



      35,295



      35,295



      1.4

      %

      Income tax expense

      —



      —



      —



      —



      —



      93,266



      93,266



      3.6

      %

      Non-operating pension and OPEB items

      —



      —



      —



      —



      —



      (1,810)



      (1,810)



      (0.1)

      %

      Adjusted EBITDA

      $

      384,854



      $

      248,743



      $

      193,890



      $

      827,487



      $

      28,931



      $

      (114,300)



      $

      742,118



      28.6

      %

















      Nine months ended September 30, 2018:
















      Net income (loss) attributable to Albemarle
      Corporation

      $

      315,939



      $

      187,176



      $

      387,038



      $

      890,153



      $

      1,659



      $

      (327,846)



      $

      563,966



      23.0

      %

      Depreciation and amortization

      71,760



      30,745



      37,201



      139,706



      6,070



      4,735



      150,511



      6.2

      %

      Non-recurring and other unusual items

      (1,439)



      —



      (218,705)



      (220,144)



      —



      81,161



      (138,983)



      (5.7)

      %

      Interest and financing expenses

      —



      —



      —



      —



      —



      39,834



      39,834



      1.6

      %

      Income tax expense

      —



      —



      —



      —



      —



      133,630



      133,630



      5.5

      %

      Non-operating pension and OPEB items

      —



      —



      —



      —



      —



      (6,596)



      (6,596)



      (0.3)

      %

      Adjusted EBITDA

      $

      386,260



      $

      217,921



      $

      205,534



      $

      809,715



      $

      7,729



      $

      (75,082)



      $

      742,362



      30.3

      %

      Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to our operating segments and are included in the Corporate category. In addition, we believe that these components of pension cost are mainly driven by market performance, and we manage these separately from the operational performance of our businesses. In accordance with GAAP, these non-operating pension and OPEB items are included in Other (expenses) income, net. Non-operating pension and OPEB items were as follows (in thousands):


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2019


      2018


      2019


      2018

      Interest cost

      $

      8,863



      $

      8,509



      $

      26,501



      $

      25,636


      Expected return on assets

      (9,414)



      (10,704)



      (28,311)



      (32,232)


      Total

      $

      (551)



      $

      (2,195)



      $

      (1,810)



      $

      (6,596)


      In addition to the non-operating pension and OPEB items disclosed above, we have identified certain other items and excluded them from our adjusted net income calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2019


      2018


      2019


      2018

      Restructuring and other(1)

      $

      —



      $

      0.04



      $

      —



      $

      0.04


      Acquisition and integration related costs(2)

      0.03



      0.03




      0.10




      0.10


      Albemarle Foundation contribution(3)

      —



      —



      —



      0.10


      Gain on sale of business(4)

      —



      —



      —



      (1.60)


      Gain on sale of property(5)

      —



      —



      (0.08)



      —


      Legal accrual(6)

      —



      0.02



      —



      0.21


      Environmental accrual(7)

      —



      —



      —



      0.11


      Other(8)

      0.05



      0.04



      0.12



      0.05


      Discrete tax items(9)

      —



      —



      0.02



      (0.11)


      Total non-recurring and other unusual items

      $

      0.08



      $

      0.13



      $

      0.16



      $

      (1.10)


















      (1)  Included in Selling, general and administrative expenses for the three and nine months ended September 30, 2018 is $3.7 million (or $0.04 per share) related to severance payments as part of a business reorganization plan.

      (2)  Acquisition and integration related costs for the three and nine months ended September 30, 2019 and 2018 related to various significant projects. Acquisition and integration related costs are included in the consolidated statements of income as follows (in millions, except per share amounts):


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,


      2019


      2018


      2019


      2018

      Acquisition and integration related costs:








      Cost of goods sold

      $

      —



      $

      0.9



      $

      —



      $

      2.9


      Selling, general and administrative expenses

      4.1



      3.4



      14.4



      10.2


      Total

      $

      4.1



      $

      4.3



      $

      14.4



      $

      13.1


      Total acquisition and integration related costs,
      after income taxes

      $

      3.2



      $

      3.5



      $

      11.1



      $

      10.7


      Total acquisition and integration related costs,
      per diluted share

      $

      0.03



      $

      0.03



      $

      0.10



      $

      0.10


      (3)  Included in Selling, general and administrative expenses for the nine months ended September 30, 2018 is a $15.0 million ($11.5 million after income taxes, or $0.10 per share) charitable contribution, using a portion of the proceeds received from the Polyolefin Catalysts Divestiture, to the Albemarle Foundation, a non-profit organization that sponsors grants, health and social projects, educational initiatives, disaster relief, matching gift programs, scholarships and other charitable initiatives in locations where our employees live and operate. This contribution is in addition to the ordinary annual contribution made to the Albemarle Foundation by the Company, and is significant in size and nature in that it is intended to provide more long-term benefits in the communities where we live and operate.

      (4)  Included in Gain on sale of business, for the nine months ended September 30, 2018 is $218.7 million ($176.7 million after discrete incomes taxes, or $1.60 per share) related to the sale of the Polyolefin Catalysts Divestiture.

      (5)  Included in Other (expenses) income, net, for the nine months ended September 30, 2019 is a gain of $11.1 million ($8.5 million after income taxes, or $0.08 per share) related to the sale of land in Pasadena, Texas not used as part of our operations.

      (6)  Included in Other (expenses) income, net, for the three and nine months ended September 30, 2018 are expenses of $0.4 million ($2.8 million including the adjustment of previously recorded income taxes, or $0.03 per share) and $10.8 million (or $0.10 per share), respectively, resulting from a settlement of a legal matter related to guarantees from a previously disposed business. In addition, Other (expenses) income, net, for the three and nine months ended September 30, 2018 include a gain of $1.4 million ($1.1 million after income taxes, or $0.01 per share) and an expense of $16.2 million ($12.5 million after income taxes, or $0.11 per share), respectively, resulting from a jury rendered verdict against Albemarle related to certain business concluded under a 2014 sales agreement for products that Albemarle no longer manufactures. Both matters were resolved and paid in 2018.

      (7)  Increase in environmental reserve of $15.6 million ($12.0 million after income taxes, or $0.11 per share) to indemnify the buyer of a formerly owned site recorded in Other (expenses) income, net. As defined in the agreement of sale, this indemnification has a set cutoff date in 2024, at which point we will no longer be required to provide financial coverage.

      (8)  Other adjustments for the three months ended September 30, 2019 included amounts recorded in:

      • Cost of goods sold - $0.1 million related to non-routine labor and compensation related costs in Chile that are outside normal compensation arrangements.
      • Selling, general and administrative expenses - $1.1 million of a write-off of uncollectable accounts receivable from a terminated distributor in the Bromine Specialties segment.
      • Other (expenses) income, net - $3.1 million of unrecoverable vendor costs outside the operations of the business related to the construction of the future Kemerton production facility, as well as a net loss of $0.4 million primarily resulting from the settlement of legal matters related to previously disposed businesses or recorded in purchase accounting.

      After income taxes, these charges totaled $5.4 million, or $0.05 per share.

      Other adjustments for the nine months ended September 30, 2019 included amounts recorded in:

      • Cost of goods sold - $0.6 million related to non-routine labor and compensation related costs in Chile that are outside normal compensation arrangements.
      • Selling, general and administrative expenses - Expected severance payments to be made in 2019 as part of a business reorganization plan of $5.3 million, with the unpaid balance recorded in Accrued expenses, $1.0 million of shortfall contributions for our multiemployer plan financial improvement plan, and $1.1 million of a write-off of uncollectable accounts receivable from a terminated distributor in the Bromine Specialties segment.
      • Other (expenses) income, net - $3.1 million of unrecoverable vendor costs outside the operations of the business related to the construction of the future Kemerton production facility, a net loss of $0.4 million primarily resulting from the settlement of legal matters related to previously disposed businesses or recorded in purchase accounting, and $0.9 million of a net loss primarily resulting from the revision of indemnifications and other liabilities related to previously disposed businesses.

      After income taxes, these charges totaled $12.3 million, or $0.12 per share.

      Other adjustments for the three months ended September 30, 2018 included amounts recorded in:

      • Cost of goods sold - $3.8 million for the write-off of fixed assets related to a major capacity expansion in our Jordanian joint venture.
      • Selling, general and administrative expenses - $0.1 million gain related to a refund from Chilean authorities due to an overpayment made in a prior year, partially offset by a $1.2 million contribution, using a portion of the proceeds received from the Polyolefin Catalysts Divestiture, to schools in the state of Louisiana for qualified tuition purposes. This contribution is significant in size and is intended to provide long-term benefits for families in the Louisiana community.
      • Other (expenses) income, net - $0.2 million gain related to the revision of previously recorded expenses of disposed businesses.

      After income taxes, these charges totaled $4.4 million, or $0.04 per share.

      Other adjustments for the nine months ended September 30, 2018 included amounts recorded in:

      • Cost of goods sold - $4.9 million for the write-off of fixed assets related to a major capacity expansion in our Jordanian joint venture.
      • Selling, general and administrative expenses - $1.5 million gain related to a refund from Chilean authorities due to an overpayment made in a prior year, partially offset by a $1.2 million contribution, using a portion of the proceeds received from the Polyolefin Catalysts Divestiture, to schools in the state of Louisiana for qualified tuition purposes. This contribution is significant in size and is intended to provide long-term benefits for families in the Louisiana community.
      • Other (expenses) income, net - $0.8 million related to the revision of previously recorded expenses of disposed businesses.

      After income taxes, these charges totaled $5.3 million, or $0.05 per share.

      (9)  Included in Income tax expense for the nine months ended September 30, 2019 are discrete net tax expenses of $2.3 million, or $0.02 per share. This net expense is primarily related to expenses for uncertain tax positions and foreign return to accrual adjustments, partially offset by a benefit for excess tax benefits realized from stock-based compensation arrangements.

      Included in Income tax expense for the three and nine months ended September 30, 2018 are discrete net tax expenses (benefits), excluding the discrete tax expense on the gain of sale of business noted above, of $0.2 million, or less than $0.01 per share, and ($11.6) million, or ($0.11) per share, respectively. The net expense for the three months is primarily related to $1.9 million expense recorded for stock-based compensation arrangements and $1.7 million expense for adjustments related to the accounting for the TCJA, partially offset by a $2.0 million benefit from foreign accrual to return adjustments and a $1.2 million benefit from the release of foreign valuation allowances. The net benefit for the nine months is primarily related to an $8.0 million benefit for tax accounting method changes, a $4.8 million benefit for adjustments related to the accounting for the TCJA, $5.4 million excess tax benefits realized from stock-based compensation arrangements, and a $2.0 million benefit from foreign accrual to return adjustments, partially offset by $7.3 million expense for adjustments to foreign valuation allowances.

      See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reported in accordance with GAAP (in thousands, except percentages).


      Income before
      income taxes and
      equity in net income
      of unconsolidated
      investments


      Income tax expense


      Effective income tax
      rate

      Three months ended September 30, 2019:






      As reported

      $

      163,723



      $

      25,341



      15.5

      %

      Non-recurring, other unusual and non-operating pension and OPEB
      items

      8,345



      391




      As adjusted

      $

      172,068



      $

      25,732



      15.0

      %







      Three months ended September 30, 2018:






      As reported

      $

      154,565



      $

      33,167



      21.5

      %

      Non-recurring, other unusual and non-operating pension and OPEB
      ems

      9,475



      (2,237)




      As adjusted

      $

      164,040



      $

      30,930



      18.9

      %







      Nine months ended September 30, 2019:






      As reported

      $

      484,653



      $

      93,266



      19.2

      %

      Non-recurring, other unusual and non-operating pension and OPEB
      items

      14,002



      (1,432)




      As adjusted

      $

      498,655



      $

      91,834



      18.4

      %







      Nine months ended September 30, 2018:






      As reported

      $

      664,993



      $

      133,630



      20.1

      %

      Non-recurring, other unusual and non-operating pension and OPEB
      items

      (145,579)



      (18,253)




      As adjusted

      $

      519,414



      $

      115,377



      22.2

      %

      SOURCE Albemarle Corporation

      Modal title

      Also from this source

      Albemarle Reports Third Quarter 2026 Results

      Albemarle Reports Third Quarter 2026 Results

      Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its ...

      Albemarle Announces Quarterly Common Stock Dividend

      Albemarle Announces Quarterly Common Stock Dividend

      The Board of Directors of Albemarle Corporation (NYSE: ALB) today announced that it declared a quarterly common stock dividend of $0.41 per share....

      More Releases From This Source

      Explore

      Chemical

      Chemical

      Mining & Metals

      Mining & Metals

      Mining

      Mining

      Oil & Energy

      Oil & Energy

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.